Document is current
Any future updates will be listed below
-
Authors
Ridgway, Jessica P. https://orcid.org/0000-0002-6939-6096
Ajith, Aswathy
Friedman, Eleanor E.
Mugavero, Michael J.
Kitahata, Mari M.
Crane, Heidi M.
Moore, Richard D.
Webel, Allison
Cachay, Edward R.
Christopoulos, Katerina A.
Mayer, Kenneth H.
Napravnik, Sonia
Mayampurath, Anoop
-
Funding
Funding for this research was provided by:
National Institutes of Health (R24 AI067039, P30 AI027767, P30 AI027757, P30 AI036214, P30 AI027763, P30 AI036219, P30 AI094189, P30 AI060354, P30 AI50410)
National Institute of Mental Health (1K23MH121190-01)
- License Information
-
More Information
Article History
Accepted: 23 March 2022
First Online: 8 April 2022
Declarations
:
: Edward Cachay has received research grants paid to UC Reagents from Gilead Sciences and Merck & Co., Inc., and has been on an advisory board for Gilead Sciences. Jessica Ridgway reports serving as an expert witness on a legal case for Gilead Sciences.
: The study was approved by the University of Chicago Institutional Review Board.
: Informed consent was obtained for all individuals involved in the study.
: N/A.
